万灵科制药[1](英语:Mallinckrodt Pharmaceuticals)是一家总部设在爱尔兰的美国制药公司,1867年成立,产品有肾上腺皮质激素仿制药成像剂[2]2017年,该公司90%的营业额来自美国医疗卫生系统。[3]

参考资料 编辑

  1. ^ 文景. 申请破产!美国又有制药商出大事. xw.qq.com. [2021-01-15]. (原始内容存档于2022-03-04) (中文(中国大陆)). 
  2. ^ Mallinckrodt . The Wall Street Journal. 1 July 2013 [2021-01-15]. (原始内容存档于2013-12-10). 
  3. ^ Mallinckrodt agrees deal to exploit Irish tax base. Irish Independent. 8 April 2014 [2021-01-15]. (原始内容存档于2022-03-04). Pharma firm Mallinckrodt has agreed to buy Questcor Pharmaceuticals for $5.6bn (€4bn) to add specialty drugs in the latest industry deal that moves a US company to Ireland for a lower tax rate. Mallinckrodt, with a registered headquarters in Dublin and run from Hazelwood, Missouri, will pay $86.08 a share for Anaheim, California-based Questcor.